The most plausible lead explanation is that SF-539 addiction to SPNS1 reflects a pre-existing reliance on lysosomal lipid salvage and autophagic flux. SPNS1 exports lysolipids (LPC/LPE and sphingosine) from the lysosome to the cytosol, enabling their reuse in membrane synthesis; loss of SPNS1 causes lysolipid buildup and broad lipid-handling defects. SF-539 shows strong dependencies on SLC22A5 and RAB18, consistent with high fatty-acid oxidation and LD–autophagy coupling that depend on continued lipid recycling. A frameshift in NCOA7 likely dampens IFN-inducible lysosome acidification via the V-ATPase, reducing lysosomal resilience. Taken together, these factors create a single point of failure for lysosomal lipid salvage and autophagic flux in SF-539, making SPNS1 KO particularly lethal. In other words, SPNS1 loss is most toxic in lipid-recycling–dependent cellular states like SF-539.

Second, several factors likely contribute but are not as direct as the primary lipid-recycling dependence. The IFN‑high state suggested by USP18/ISG15 dependence points to broader lysosome stress and may amplify SPNS1 addiction by stressing acidification and proteolysis pathways. The SGMS2 missense changes could subtly shift SM/PC flux, sensitizing cells to lysosomal lipid-traffic defects, though this link is more correlative. Additional background mutations in TP53, RB1, and STAG2 may raise basal autophagy demand and cellular stress, pushing lysosome/autophagy nodes toward the edge. These features don’t by themselves define SPNS1 dependence but create a cellular milieu in which lysosomal defects become more lethal when SPNS1 is removed. Overall, they act as modifiers that sharpen rather than initiate the SPNS1 addiction in SF-539.

Other interesting facts and testable observations include several concrete predictions. Rescue by extracellular choline or phosphatidylcholine would support a LPC-derived choline salvage mechanism, whereas choline limitation should worsen SPNS1 dependency. SPNS1 KO should lead to accumulation of intralysosomal LPC/LPE/sphingosine and impaired autophagic flux, measurable by lipidomics and autophagy readouts. Re-expressing the IFN‑inducible short NCOA7 isoform with an intact TLDc domain should mitigate lysosome acidification defects if the frame in SF‑539 is contributing; a truncated endogenous allele would likely fail to rescue. The genetic link between SPNS1 and V‑ATPase–driven acidification predicts that even subtle changes in lysosomal pH will tilt viability in SF‑539. Finally, SF‑539 comes from a CNS lineage, a context often marked by high metabolic and autophagic demand, which may predispose it to SPNS1 addiction.